28-7 Therapeutics' Series A Round

28-7 Therapeutics raised a round of funding on September 07, 2018.

28-7 Therapeutics has a small-molecule program that aims to increase the levels of the tumor suppressor microRNA Let-7, which regulates the translation of oncogenes within cells. Low levels of Let-7 h…

Articles about 28-7 Therapeutics' Series A Round: